omidenepag
Sign in to saveAlso known as UR-7276, UR 7276
Omidenepag, sold under the brand name Eybelis among others, is a medication used for the treatment of glaucoma and ocular hypertension.
Wikidata facts
- Mass
- 478.1423241840001
Show 2 more facts
- canonical SMILES
- C1=CC(=NC(=C1)NCC(=O)O)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4
- chemical formula
- C₂₃H₂₂N₆O₄S
Sources (1)
via Wikidata · CC0
~1 min read
Article
6 sectionsContents
- Medical uses
- Adverse effects
- Pharmacology
- History
- References
- External links
Omidenepag, sold under the brand name Eybelis among others, is a medication used for the treatment of glaucoma and ocular hypertension.
Omidenepag was approved for medical use in Japan in 2018, and in the United States in September 2022.
Connections
brinzolamide
Entity
macular retinal edema
Entity
medication
Entity
digital object identifier
Entity
chemical formula
Entity
glaucoma
Entity
conjunctivitis
Entity
ester
Entity
molar mass
Entity
hydrolysis
Entity
Q180686
Entity
acetylcholine
Entity
bibcode
Entity
CAS Registry Number
Entity
Q229883
Entity
PubChem
Entity
United States Food and Drug Administration
Entity
Anatomical Therapeutic Chemical Classification System
Entity
beta blocker
Entity
simplified molecular input line entry specification
Entity
Categories
3-Pyridyl compoundsAcetic acidsAlpha-Amino acidsChemical articles with multiple CAS registry numbersChemical articles with multiple PubChem CIDsCosmetics chemicalsDisubstituted pyridinesDrugs with non-standard legal statusHair loss medicationsInfobox drug with local INN variantIsopropyl estersMultiple chemicals in an infobox that need indexingMultiple chemicals in Infobox drugOphthalmology drugsProdrugsPyrazolesSulfonamides